Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 study of HTD1801 in adults with nonalcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM) completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial assessing the efficacy and safety of elobixibat in combination with cholestyramine for nonalcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of PXL770 versus placebo in adults with nonalcoholic fatty liver disease (NAFLD). …
-
CLINICAL_TRIALS trial_result · 2021-10-21Clinical Trial Update: Losartan for the Treatment of Pediatric NAFLD [Phase 2]
Phase 2 trial investigating losartan for pediatric nonalcoholic fatty liver disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH [Phase 3]
Phase 3 study update evaluating MSDC-0602K for glycemic control and cardiovascular outcomes in pre-diabetes/Type 2 diabetes with NAFLD/NASH;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease [Phase 4]
Phase IV trial evaluating statin monotherapy or statin/ezetimibe with respect to hepatic steatosis in patients with hyperlipidemia and nonal…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir [Phase 4]
Phase 4 trial evaluating the effect on liver fat and metabolic parameters when switching a protease inhibitor or efavirenz to raltegravir in…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery [NA]
Clinical trial update studying biomarkers of liver pathology in patients with presumed non-alcoholic steatohepatitis after bariatric surgery…
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]
Phase 2 trial evaluating MET409 alone or with empagliflozin in patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents [EARLY_Phase 1]
Early-phase trial assessing growth hormone to treat nonalcoholic fatty liver disease in adolescents has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass [NA]
Clinical trial update on a low-calorie diet and body composition before Roux-en-Y gastric bypass; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout [Phase 2]
Phase 2 trial investigating febuxostat for lowering uric acid in patients with nonalcoholic fatty liver disease and gout.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment [Phase 2, Phase 3]
Phase 2/3 clinical trial update assessing safety and tolerability of novel medical nutrition products for NAFLD/NASH treatment.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 study of ISIS 703802 in participants with hypertriglyceridemia, type 2 diabetes, and nonalcoholic fatty liver disease has completed …
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH) [Phase 3]
Investigator-initiated Phase 3 randomized trial comparing saroglitazar, vitamin E, and lifestyle modification for NAFLD/NASH.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Anti-LPS Antibody Treatment for Pediatric NAFLD [Phase 2]
Phase 2 trial update for anti-LPS antibody in pediatric NAFLD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy [Phase 2]
Phase 2 clinical protocol update assessing long-term safety and efficacy of metreleptin in various forms of partial lipodystrophy; study sta…
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Curcumin Supplement in Nonalcoholic Fatty Liver Patients [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial assessment of curcumin supplement in patients with type 2 diabetes and nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Rifaximin in Fatty Liver Disease [Phase 4]
Phase 4 trial of rifaximin for fatty liver disease was terminated; results posted but status terminated.
-
CLINICAL_TRIALS trial_result · 2020-08-17Clinical Trial Update: Study of Gemcabene in Adults With FPLD [Phase 1, Phase 2]
Phase 1/2 trial updates for gemcabene in adults with familial partial lipodystrophy (FPLD) and hypertriglyceridemia have been completed with…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: LAGB as a Treatment for Morbid Obesity in Adolescents [NA]
Clinical trial update for LAGB (laparoscopic adjustable gastric banding) as a treatment for obesity in adolescents; study status completed w…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 2]
Phase 2a dose-ranging study of PF-05221304 in nonalcoholic fatty liver disease/nonalcoholic steatohepatitis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Dietary Treatment Study of Pediatric NAFLD [NA]
Clinical trial update for a dietary treatment study in pediatric nonalcoholic fatty liver disease (NAFLD) completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Tesamorelin Effects on Liver Fat and Histology in HIV [NA]
Clinical trial update reporting on tesamorelin effects on liver fat and histology in HIV patients with NAFLD/NASH; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial comparing salsalate to placebo in osteoarthritis patients with nonalcoholic fatty liver disease has been completed.